Utility of a Risk Priority Number in Managing Safety Event Reports in a Radiation Oncology Department
Jean L. Wright(University of North Carolina at Chapel Hill), T.R. McNutt(Johns Hopkins University), Shaw Ng(Johns Hopkins University), Akila N. Viswanathan(Johns Hopkins University), Elwood P. Armour(Johns Hopkins Hospital), Theodore L. DeWeese(Johns Hopkins University), A. Parekh(Johns Hopkins University), Byung Han Rhieu(Johns Hopkins University), A.N. Souranis(Johns Hopkins Hospital), Adam V. Metzler(University of Miami), Stephanie A. Terezakis(Johns Hopkins University), Amanda Choflet(Sidney Kimmel Comprehensive Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 0
Related Papers
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|776
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer
|International Journal of Radiation Oncology*Biology*Physics|2010|458
The life and death of DNA-PK
|Oncogene|2004|407
Effectiveness of early orthodontic treatment with the twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|374